OtherMay 20, 2026, 04:42 PM
COSCIENS Biopharma Inc. Files 6-K with Exhibits
AI Summary
This is a 6-K filing from COSCIENS Biopharma Inc. with exhibits. The exhibits themselves contain no discernible information.
Price Impact
More from CSCIF
Corporate Action3h ago
COSCIENS Biopharma Appoints Permanent CEO; Approves Share Capital Amendment
Quarterly ResultMay 12, 5:12 PM
COSCIENS Biopharma Reports Q1 Net Income $10.76M; German Subsidiary Deconsolidation
Quarterly ResultMay 12, 5:11 PM
COSCIENS Biopharma Q1 Net Income $10.8M; Plans to Suspend SEC Reporting